Ben George, MD

William F. Stapp Endowed Chair; Associate Professor of Medicine; Director, Phase 1 Clinical Trials Program; Associate Director for Cancer Genomics and Precision Medicine; Genomic Sciences and Precision Medicine Center

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Hospital

Specialties

Hematology
Medical Oncology

Languages

English, Malayalam

Contact Information

(414) 805-0505

Education

MD - Doctor of Medicine

Biography

Dr. George graduated from Medical College Thiruvananthapuram, in Kerala, India in 1998. He was a PhD candidate in Pathology at the Keck School of Medicine (University of Southern California) in Los Angeles, CA from 1999-2004. In 2005, Dr. George completed an internship in Internal Medicine at the Medical College of Ohio and subsequently his residency at Gunderson Lutheran Medical Center in La Crosse, WI. He then completed a fellowship in Hematology and Oncology at the Medical College of Wisconsin (2007-2010). Most recently, Dr. George completed a dedicated fellowship in Gastrointestinal Medical Oncology at the MD Anderson Cancer Center in Houston, Texas. He is board certified in medical oncology and hematology.

Research Interests

Dr. Ben George joined the Medical College of Wisconsin faculty in 2011 as an Associate Professor of Medicine in the Division of Hematology and Oncology. Dr. George specializes in Gastrointestinal Medical Oncology. His interests include colorectal cancer, pancreatic cancer, gastric cancer, esophageal cancer, small bowel and appendiceal neoplasms, cholangiocarcinoma, and hepatocellular carcinoma. His current research interests are focused on colorectal cancer and pancreatic cancer.

Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

(Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.) Ann Surg Oncol. 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer.

(Abid MB, Chhabra S, Buchan B, Graham MB, Abedin S, Thapa B, D'Souza A, George B, Hamadani M.) Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):65-70 PMID: 33058787 PMCID: PMC7543702 SCOPUS ID: 2-s2.0-85092735525 10/16/2020
Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.

(Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY.) Surgery. 2021 Mar;169(3):629-635 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020
DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells.

(Chung J, Maruvka YE, Sudhaman S, Kelly J, Haradhvala NJ, Bianchi V, Edwards M, Forster VJ, Nunes NM, Galati MA, Komosa M, Deshmukh S, Cabric V, Davidson S, Zatzman M, Light N, Hayes R, Brunga L, Anderson ND, Ho B, Hodel KP, Siddaway R, Morrissy AS, Bowers DC, Larouche V, Bronsema A, Osborn M, Cole KA, Opocher E, Mason G, Thomas GA, George B, Ziegler DS, Lindhorst S, Vanan M, Yalon-Oren M, Reddy AT, Massimino M, Tomboc P, Van Damme A, Lossos A, Durno C, Aronson M, Morgenstern DA, Bouffet E, Huang A, Taylor MD, Villani A, Malkin D, Hawkins CE, Pursell ZF, Shlien A, Kunkel TA, Getz G, Tabori U.) Cancer Discov. 2020 Dec 18 PMID: 33355208 12/24/2020
Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

(Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2020 Dec 03 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.

(Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S.) HPB (Oxford). 2020 Dec;22(12):1745-1752 PMID: 32354656 SCOPUS ID: 2-s2.0-85083782398 05/02/2020
Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer.

(Wainberg ZA, Hochster HS, Kim EJ, George B, Kaylan A, Chiorean EG, Waterhouse DM, Guiterrez M, Parikh A, Jain R, Carrizosa DR, Soliman HH, Lila T, Reiss DJ, Pierce DW, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, O'Dwyer PJ.) Clin Cancer Res. 2020 Sep 15;26(18):4814-4822 PMID: 32554514 06/20/2020
Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.

(Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S.) Surgery. 2020 09;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020
Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?

(Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S.) J Gastrointest Surg. 2020 02;24(2):235-242 PMID: 31745905 SCOPUS ID: 2-s2.0-85076028351 11/21/2019
Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy.

(Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S.) Front Oncol. 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer.

(Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S.) Front Oncol. 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer.

(Goldman JW, Waterhouse DM, George B, O'Dwyer PJ, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, Kelly K.) Front Oncol. 2019;9:1256 PMID: 31850192 PMCID: PMC6901975 12/19/2019